A comparative uncertainty study of the calibration of macrolide antibiotic reference standards using quantitative nuclear magnetic resonance and mass balance methods

Analytica Chimica Acta

Volumn 602, Issue 1, 2007, Pages 114-121

  Liu, Shu Yu ^a,b   Hu, Chang Qin ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Mass balance method; Quantitative nuclear magnetic resonance; Reference standard; Uncertainty

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; OPTIMIZATION; PARAMETER ESTIMATION; RESEARCH AND DEVELOPMENT MANAGEMENT;

MASS BALANCE METHOD; QUANTITATIVE NUCLEAR MAGNETIC RESONANCE; REFERENCE STANDARDS; UNCERTAINTY;

ANTIBIOTICS;

AZITHROMYCIN; CLARITHROMYCIN; DIRITHROMYCIN; MACROLIDE; MIDECAMYCIN; ROXITHROMYCIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; COMPARATIVE STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATHEMATICAL MODEL; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STANDARD; UNCERTAINTY;

ANTI-BACTERIAL AGENTS; CALIBRATION; MACROLIDES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; REFERENCE STANDARDS; UNCERTAINTY;

EID: 34948883306     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2007.09.009     Document Type: Article

References (22)

1. World Health Organization, General guidelines for the establishment, maintenance and distribution of chemical reference substance, in: WHO Technical Report Series, No. 885, Part A, 5, Geneva, 1999.
2. The Directorate for the Quality of Medicines of the Council of Europe, Establishment of reference standards, in: European Pharmacopoeia, fifth ed., Supplement 5.6, General texts 5.12.4, Council of Europe, Strasbourg, 2007.
3. World Health Organization, Evaluation of chemical reference substance, in: International Pharmacopoeia, third ed., vol. 5, Supplementary information, Part A, 3.3, World Health Organization, Geneva, 2003.
4. Holzgrabe U., Diehl B.W.K., and Wawer I. J. Pharm. Biomed. Anal. 7 (1998) 57
5. Choi Y.H., Kim H.K., Wilson E.G., Erkelens C., Trijzelaar B., and Verpoorte R. Anal. Chim. Acta 512 (2004) 141
6. Kim H.K., Choi Y.H., Chang W.T., and Verpoorte R. Chem. Pharm. Bull. 51 (2003) 1382
7. Hazekamp A., Choi Y.H., and Verpoorte R. Chem. Pharm. Bull. 52 (2004) 718
8. Li C.Y., Lin C.H., and Wu T.S. Chem. Pharm. Bull. 53 (2005) 347
9. Jaki B., Franzblau S.G., and Pauli G.F. Phytochem. Anal. 15 (2004) 213
10. Talebpour Z., Haghgoo S., and Shamsipur M. Anal. Chim. Acta 506 (2004) 97
11. The United States Pharmacopeial Convention Inc. The United States Pharmacopoeia. 29th ed. (2006), The United States Pharmacopeial Convention, Inc., Rochville, MD
12. The Directorate for the Quality of Medicines of the Council of Europe. European Pharmacopoeia. fifth ed. (2005), Council of Europe, Strasbourg
13. Lu R.Z. World Notes on Antibiotics 18 (1997) 125
14. Miguel L., and Barbas C. J. Pharm. Biomed. Anal. 33 (2003) 211
15. Morgan D., Cugier P., Marello B., Sarocka C., Stroz D., and Plasz A. J. Chromatogr. 502 (1990) 351
16. Malz F., and Jancke H. J. Pharm. Biomed. Anal. 38 (2005) 813
17. The State Pharmacopoeia Commission of PR China. Pharmacopoeia of the People's Republic of China Edition 2005 (2005), Chemical Industry Press, Beijing
18. International Organization for Standardization, Guide to the Expression of Uncertainty in Measurement (GUM), International Organization for Standardization (ISO)/International Electrotechnical Commission (IEC), Guide 98, 1995.
19. Pauli G.F., Jaki B.U., and Lankin D.C. J. Nat. Prod. 68 (2005) 133
20. Burton I.W., Quilliam M.A., and Walter J.A. Anal. Chem. 77 (2005) 3123
21. Maniara G., Rajamoorthi K., Rajan S., and Stokton G.W. Anal. Chem. 70 (1998) 4921
22. Wells R.J., Hook J.M., Al-Deen T.S., and Hibbert D.B. J. Agric. Food Chem. 50 (2002) 3366